27th Annual Pharmaceutical
and Medical Device Ethics
and Compliance Congress
October 13-16, 2026

Hybrid Onsite Conference & Internet Event — Live and Archived
Washington Hilton
Washington, DC

Follow Pharma Congress on:  


Home

CONGRESS REGISTRATION IS NOW OPEN.

THE 2026 27TH ANNUAL CONGRESS FEATURES:

  • New half-day specialty summits on the afternoon of Tuesday 10/13
  • Over 50 concurrent mini summits and 15 plenary session presentations
  • The PCF-sponsored, Closed-door, invitation-only CCO Roundtable, last year attended by over 100 CCOs
  • The Industry-only Compliance Best Practices Think Tank hosted by PCF
  • A sold-out exhibit hall featuring many innovative ethics and compliance products, programs and initiatives
  • Numerous professional networking opportunities


    • FEATURED ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL

    Peter Agnoletto, CPA

    Compliance Officer, General Medicines and Consumer Health Care, Sanofi; Former Senior Director & CCO, Par Pharma, Bridgewater, NJ

    Kaoutar Afif

    Manager, Ethics & Compliance, Cardinal Health, New York, NY

    Peter Brensilver, JD, MPH

    Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY

    Terra Buckley, JD

    Chief Compliance & Ethics Officer, Bristol Myers Squibb; Former CCO, LivaNova, Summit, NJ

    Briana Cabrera, MS, CFE

    Senior Director, Global Privacy & Compliance Investigations, Medtronic; Former Director, Forensic Audit, Covidien, Miami, FL

    Regina Cavaliere, JD

    Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY

    Kevin Espinoza, MBA

    Chief Integrity & Compliance Officer, Indivior; Former Chief Integrity & Compliance Officer, Kaleo; Former Senior VP, Boston Scientific, Richmond, VA

    Yelena Ferreira, JD

    Assistant GC & Head of Compliance, Pharmacosmos; Former Senior Director, Associate General Counsel, Pacira, Morristown, NJ

    Lindsey LaMoria Gavin

    Senior Director, Deputy Compliance Officer, Lundbeck; Former Compliance Director, Meetings & Events International, Deerfield, IL

    Kate Godfrey, JD, CCEP

    Senior VP, Global Chief Compliance Officer, Chief Compliance Officer KSNA, Karl Storz North America, El Segundo, CA

    Abe Kassis, MBA, PhD

    Global Head Compliance & Legal Operations, Bausch + Lomb; Former Global Compliance Director, Takeda, New York, NY

    Jeffrey Kawalek, MBA

    Chief Compliance Officer, Zambon US; Former Deputy CCO US, Jazz; Former Co-chair, PCF, New York, NY

    Cheryl Lee, MBA, CHC

    Head of Compliance, Cycle; Former VP, ESG Strategy & Execution, BMS; Former VP, Head of Compliance Worldwide Markets, Celgene, New York, NY

    Peter Lee, JD, LLM

    Chief Compliance Officer, Kura Oncology; Former CCO, Mirati Therapeutics; Former CCO, Heron Therapeutics, San Diego, CA

    Aaron Lewis, MBA

    Director, Legal and Compliance Operations, Cordis; Former Director, Compliance Insights and Technologies, Cardinal Health, Miami Lakes, FL

    Melissa T. Lozner, JD

    Senior VP, CCO, Regeneron; Former Chief Compliance & Ethics Officer, Rafael Holdings; Former VP, Head of Ethics, Risk & Compliance, Novartis, Tarrytown, NY

    Rosemary McKenna, JD

    Executive Director, Regulatory Legal, Organon; Former Director, Regulatory-Legal, Merck, Philadelphia, PA

    Joan Podleski, CCEP, CHPC, CHRC, CHC

    VP & CPO, Children’s Health System of Texas; Former Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX

    Ariadna Quesada, MSJ

    VP, Compliance, Global Compliance & Privacy lead, ZOLL Medical; Former Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain

    R. Brett Short, CHC, CHPC, CHRC

    CCO & CPO, University of Kentucky; Immediate Past Chair, Health Care Compliance Association, Lexington, KY

    Jesse Siegel, JD

    Head of Business Ethics, Americas, Ipsen; Former Senior Counsel, Neurology & Immunology, EMD Serono, Cambridge, MA

    Ronald Strauss, CIPM

    Vice President Compliance, MiMedx; Former Executive Sales Representative, Eli Lilly Specialty, Marietta, GA

    Betsy Wade, MPH, CHC, CHPC, CAN

    Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY

    Kelly Willenberg, MBA, DBA, CHC, CHRC

    Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC

    Elizabeth Weiss, JD

    VP, Chief Compliance & Privacy Officer, Invivyd; Former Head of Compliance for Americas & EMEA, Lupin; Former Assistant GC, Compliance Lead, Global Health & Patient Access, Pfizer, Livingston, NJ

    Amy Wilson, MBA, MSJ

    VP & CCO, Esperion; Former Head of US Compliance, MorphoSys; Former Director, Enterprise Compliance, Alexion, Boston, MA

    Suki Wiltman

    Vice President, Global Ethics & Compliance, Ipsen; Former Business Partner, Governance, Ethics & Compliance, GSK; Former Sr Corporate Compliance Manager, Allergan Canada, Toronto, Canada

    Stacy E. Yeung, JD

    VP & GC, SELLAS; Former Assistant General Counsel, Arena Pharmaceuticals; Former Deputy General Counsel, DBV Technologies, New York, NY


    FORMER GOVERNMENT OFFICIALS

    Corey R. Amundson, JD

    Partner, King & Spalding; Former Head, Public Integrity Section, US DOJ; Former Acting US Attorney, Middle District of Louisiana, Washington, DC

    Jennifer L. Bragg, JD

    Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC

    Hui Chen, JD

    Co-Founder, Culture. Data. Ethics; Former Compliance Counsel Expert, US DOJ; Former Assistant General Counsel, Pfizer, Honolulu, HI

    Deborah A. Curtis, JD

    Partner, Arnold & Porter; Former Deputy GC, CIA; Former Deputy Chief, Counterespionage, US DOJ, Washington, DC

    John Delacourt, JD

    Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Former Chief Antitrust Counsel, FTC, Washington, DC

    Greg Demske, JD

    Partner, Goodwin Procter; Former Chief Counsel, Office of Inspector General, US HHS, Washington, DC

    Sarah A. Franklin, JD

    Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Former Attorney, US FTC, Washington, DC

    Gejaa T. Gobena, JD

    Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

    John Kelly, JD

    Partner & Chair, Healthcare Practice, Barnes & Thornburg; Former Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC

    Barbara A. Leaf, JD

    Senior International Policy Advisor, Arnold & Porter; Former Special Assistant to the President; Former US Ambassador, UAE, Washington, DC

    Christine Moundas, JD, MPH

    Healthcare & Data Partner & Co-Head, Digital Health Initiative, Ropes & Gray; Former Analyst, Office of Inspector General, US HHS, New York, NY

    Ida Nassar, JD

    Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, US Drug Enforcement Administration, Washington, DC

    Diane Seol, JD

    Of Counsel, Choate Hall & Stewart; Former Assistant United States Attorney, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, Boston, MA

    Michael L. Shaw, JD

    Global Head of Compliance, Privacy and Risk, ZS; Former VP & CO, GlaxoSmithKline; Former Senior Counsel, OIG US HHS, Princeton, NJ

    Amanda Strachan, JD

    Partner, WilmerHale; Former AUSA & Chief, Criminal Division, US Attorney’s Office, District of Massachusetts, US DOJ, Boston, MA

    Jane H. Yoon, JD

    Partner, Litigation Department, Paul Hastings; Former Assistant United States Attorney, US Attorney’s Office, New Jersey, New York, NY


    OTHER FEATURED FACULTY

    Eliza L. Andonova, JD

    Partner, Global Regulatory, Hogan Lovells, Washington, DC

    Brett Barlag, MBA

    Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY

    Samantha Barrett Badlam, JD

    Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC

    Yogesh Bahl, MBA

    Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY

    Craig B. Bleifer, JD

    Partner, McGuire Woods; Former Corporate VP, GC North America; Novo Nordisk, New York, NY

    Eric Bolesh

    Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

    Jennifer Ceglinski, JD, CFE

    Manager, Forensic & Integrity Services, EY, Charlotte, NC

    Michael Clarke, JD, CCEP, NACD.DC®

    Principal, Jaeger-Plymouth; Retired VP, Deputy GC & Global CCO, ConvaTec; Former VP, Compliance, Indivior, Bridgewater, NJ

    Chris Cobourn, MS

    Managing Director, Government Programs Practice Lead, Helio Health Group, Placida, FL

    Benjamin Correa, JD

    Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC

    Zachary Coseglia, JD

    Co-Founder, Culture. Data. Ethics; Former VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA

    Layla Covington, JD

    Senior Manager, Compliance Consulting, Cresen; Former Manager, Aggregate Spend, Genentech, Chicago, IL

    Clarissa Crain

    Managing Director, Deloitte, Phoenixville, PA

    Meena Datta, JD

    Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL

    Mahnu V. Davar, MA, JD

    Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

    Stefanie A. Doebler, JD

    Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC

    Kip Ebel, MBA

    Principal, Forensic & Integrity Services, EY, New York, NY

    Aurelie Ercoli, LLM, PhD

    Partner, Life Sciences Practice Group, DLA Piper, US, Washington, DC

    Ronnie H. Feldman

    Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL

    Alison J. Fethke, JD

    Member of the Firm, Epstein Becker Green; Former Division Counsel, Legal Regulatory & Compliance, AbbVie, Chicago, IL

    David Fisher, MS

    President, TDI Solutions; Former VP & General Manager, Cyber Innovations, Battelle, Washington, DC

    Sara K. Frank, JD

    Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA

    Gary F. Giampetruzzi, JD

    Partner & Global Chair Life Sciences, Paul Hastings; Former VP & AGC, Head of Government Investigations, Pfizer, New York, NY

    John Gitas, MBA

    Principal, US Advisory, Healthcare and Life Sciences, KPMG, New York, NY


    Noah C. Goldstein, JD

    Counsel, Porzio Bromberg & Newman; Former Compliance and Privacy Specialist, Beth Israel Deaconess Medical Center, Westborough, MA

    Neeraj Gupta, MBA

    President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA

    Kris Hall, JD, CIPP/CIPM

    Managing Director, Dovetail; Former VP, Chief Privacy Officer, Celgene; Former VP, Head of Privacy, Shire, Bridgton, ME

    Kristin M. Hicks, JD

    Partner, Arnold & Porter, Washington, DC

    Emily F. Hodge, JD

    Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA

    Casey J. Horton, CFE

    Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL

    Jeff Hyre

    Vice President Sales, Healthcare & Life Sciences, Global Relay, Denver, CO

    Katie Jacyna

    Vice President, Product Management, Helio Health Group, Denver, CO

    Mark A. Jensen, JD

    Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC

    Erin Brown Jones, MA, JD

    Partner, Latham & Watkins, Washington, DC

    Marci Juneau, MBA

    A Founding Partner, Helio Health Group, Atlanta, GA

    Olivia Krzeminski, JD

    Director of Compliance & Legal Research, G&M Health, Somerset, NJ

    Jeffrey Low, RPh, MHA

    Director, Ankura; Former VP, Clinical Services, Magellan Health; Former Director, Medicare Services, CVS/Caremark, Phoenix, AZ

    Robert Melillo, JD

    Co-founder and Managing Director, G&M Health, Cocoa Beach, FL

    Brook Mishler, RN, MSN

    Global Director of Compliance Solutions, Life Sciences, Case IQ; Former Compliance Officer for the Americas, Cordis, Ontario, Canada

    Katherine C. Norris, MPA

    Senior Managing Director, Life Sciences Compliance, Disputes & Economics, Ankura, Honolulu, HI

    Daniel O’Connor

    Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ

    John Poulin

    Chief Technology Officer and Partner, Helio Health Group, Boston, MA

    Saraswatha Lalitha Putcha, MA

    Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA

    Nikki Reeves, JD

    Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

    Russell Rose, JD

    Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX

    Jeffrey Scott, JD

    Of Counsel, Life Sciences, DLA Piper; Former Lead Compliance Counsel, Digital, Reporting, and Analytics, Pfizer, Philadelphia, PA

    Paul Silver

    Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA

    Laura A. Skinner, MBA

    Managing Director, Life Sciences & Healthcare Consulting Group, Paul Hastings; Managing Director, Rare Disease Compliance Consortium, New York, NY

    Ravneet Talwar, MBA

    Senior Manager, Life Sciences & Healthcare Consulting Group, Paul Hastings, New York, NY

    L. Stephan Vincze, JD, LLM, MBA

    President & CEO, TRESTLE Compliance; Former SVP & CCO, Warner Chilcot; Former VP & CCO, TAP, Boston, MA

    Erin Wagenberg, CIPP/US, CIPP/E, CIPT, FIP

    Director, Dovetail Consulting Group; Former Deputy Privacy Officer, Deloitte Global, Atlanta, GA

    Shannon Walker

    Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada

    Robert A. Wells, JD

    Shareholder, Baker Donelson, Baltimore, MD

    Kelly Willenberg, MBA, DBA, CHC

    Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC

    Jacob Wolf, MBA

    Chief Commercial Officer, Cresen Solutions, Orlando, FL

    Cobun Zweifel-Keegan, JD, CIPP/US

    Managing Director, IAPP; Former Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC

    THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!

    Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring timely, expert-led deep dives on the hottest issues facing pharma and device companies today. These will include sessions on Advanced Strategies Coordinating Compliance between Medial Affairs and Commercial & Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.


    AN OVERVIEW OF THE 27TH CONGRESS SCHEDULE

    Day 1: Tuesday, October 13,2026

  • Afternoon Half-day Specialty Focused Sessions

    • Day 2: Wednesday, October 14,2026

  • Networking Breakfast

  • Morning Concurrent Mini Summits

  • Networking Luncheon

  • Afternoon Opening Plenary Session

  • Networking Reception

    • Day 3: Thursday, October 15,2026

  • Networking Breakfast

  • Morning PCF CCO Roundtable (Invitation-only)

  • Morning Concurrent Mini Summits

  • Networking Luncheon

  • Afternoon Closing Plenary Session

    • Day 4: Friday, October 16,2026

  • Networking Breakfast

  • Morning PCF Industry-only Plenary Session

  • Noon: Congress Adjournment


    • AND REMEMBER THAT ALL ATTENDEES HAVE COMPLIMENTARY ACCESS TO THE CONGRESS VIRTUAL VIDEO ARCHIVE FOR 9 MONTHS FOLLOWING THE EVENT

    FEATURING THE PHARMA & MEDICAL DEVICE CONGRESS ADVANCED VIRTUAL INTERACTIVE VIDEO BROADCAST PORTAL

    Featuring one-on-one attendee video chat and large group video interactive workshops.
    See last year’s Congress portal:

    A HYBRID CONFERENCE AND INTERNET EVENT